Skip to main content

Interim Analysis of a Phase 1 Trial of SGN-CD33A in Patients with CD33-Positive Acute Myeloid Leukemia (AML)

Publication ,  Conference
Stein, EM; Stein, A; Walter, RB; Fathi, AT; Lancet, JE; Kovacsovics, TJ; Advani, AS; DeAngelo, DJ; O'Meara, MM; Zhao, B; Kennedy, DA; Erba, HP
Published in: BLOOD
December 6, 2014

Duke Scholars

Published In

BLOOD

EISSN

1528-0020

ISSN

0006-4971

Publication Date

December 6, 2014

Volume

124

Issue

21

Location

San Francisco, CA

Publisher

AMER SOC HEMATOLOGY

Conference Name

56th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stein, E. M., Stein, A., Walter, R. B., Fathi, A. T., Lancet, J. E., Kovacsovics, T. J., … Erba, H. P. (2014). Interim Analysis of a Phase 1 Trial of SGN-CD33A in Patients with CD33-Positive Acute Myeloid Leukemia (AML). In BLOOD (Vol. 124). San Francisco, CA: AMER SOC HEMATOLOGY.
Stein, Eytan M., Anthony Stein, Roland B. Walter, Amir T. Fathi, Jeffrey E. Lancet, Tibor J. Kovacsovics, Anjali S. Advani, et al. “Interim Analysis of a Phase 1 Trial of SGN-CD33A in Patients with CD33-Positive Acute Myeloid Leukemia (AML).” In BLOOD, Vol. 124. AMER SOC HEMATOLOGY, 2014.
Stein EM, Stein A, Walter RB, Fathi AT, Lancet JE, Kovacsovics TJ, et al. Interim Analysis of a Phase 1 Trial of SGN-CD33A in Patients with CD33-Positive Acute Myeloid Leukemia (AML). In: BLOOD. AMER SOC HEMATOLOGY; 2014.
Stein, Eytan M., et al. “Interim Analysis of a Phase 1 Trial of SGN-CD33A in Patients with CD33-Positive Acute Myeloid Leukemia (AML).” BLOOD, vol. 124, no. 21, AMER SOC HEMATOLOGY, 2014.
Stein EM, Stein A, Walter RB, Fathi AT, Lancet JE, Kovacsovics TJ, Advani AS, DeAngelo DJ, O’Meara MM, Zhao B, Kennedy DA, Erba HP. Interim Analysis of a Phase 1 Trial of SGN-CD33A in Patients with CD33-Positive Acute Myeloid Leukemia (AML). BLOOD. AMER SOC HEMATOLOGY; 2014.

Published In

BLOOD

EISSN

1528-0020

ISSN

0006-4971

Publication Date

December 6, 2014

Volume

124

Issue

21

Location

San Francisco, CA

Publisher

AMER SOC HEMATOLOGY

Conference Name

56th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology